Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.41 +0.00 (+0.00%)
As of: Nov 10, 2026 · 3:16 PM EST

Tvardi Therapeutics (TVRD) EV to EBIT (2020 - 2021)

Updated

Tvardi Therapeutics' EV to EBIT was 27.76 in Q3 2021, down 66.1% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) EV to EBIT (2020 - 2021) Analysis & Trends

On a trailing twelve-month basis, Tvardi Therapeutics' EV to EBIT was 5.42 through Sep 30, 2021; for FY2020, it came in at 106.52.

  • Per Business Quant data, TVRD's EV to EBIT in the three quarters before Q3 2021 was 81.89 (Q2 2021), 77.33 (Q1 2021) and 106.52 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tvardi Therapeutics 12.48 Mn -95.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 27.76
Jun 30, 2021 81.89
Mar 31, 2021 77.33
Dec 31, 2020 106.52
API Access

Tvardi Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=TVRD&period=max&api_key=YOUR_API_KEY